Sponsor: Rubicon Genomics
Recording Date: 2/19/2014
Recording Time: 1 hour
● Design and develop pipelines to automate analysis workflows across various data types and platforms for gene discovery and clinical applications
● Extract, manipulate, transform and analyze various data sets from gene discovery and clinical validation efforts
● Utilize understanding and experience in assessing data quality and data normalization for a variety of genomic platforms
● Evaluate and integrate various bioinformatics tools and resources for annotation and interpretation of diverse types of data
● Apply knowledge of classification methods to generate gene signatures for disease classification and prediction. Participate in development, implementation and testing of various novel methods
● Collaborate with various groups on reports, presentations and research publications
● PhD/MS in Bioinformatics/Computer Science/Statistics or a related discipline
● Minimum 1 year relevant experience required
● Strong programming skills in R, Perl shell scripting are essential
● Knowledge and proficiency in Java or C/C++ desired
● Working knowledge with one or more of Oracle/Postgres/mySQL databases
● Demonstrated experience in software engineering
● Experience in analysis of gene expression, proteomic, genetic or other genomic data sets desired
• Knowledge of computer systems and technologies
• Knowledge of databases
• Basic understanding of analytical techniques associated with analysis of high throughput microarray and/or Next-Generation sequencing data
• Knowledge of Perl, R, C, Python and general programming languages
Please email email@example.com
HTG Molecular was founded as a life sciences company in Tucson, Arizona in 1997, with the mission to develop a universal molecular biology-based platform that would improve the pharmaceutical drug discovery process. This novel technology is known as qNPA. Since that time, HTG Molecular has expanded the utility of the qNPA technology into the fields of gene expression profiling, translational medicine and clinical research. Applications include the measurement of mRNA and miRNA in a variety of sample types, especially in formalin-fixed, paraffin embedded (FFPE) tissue.
HTG Molecular has a large menu of array components and is continuously adding more to support CLIA labs in custom array assays. HTG Molecular is developing proprietary gene expression assays for a variety of tissue types and disease states.
In the near future, HTG Molecular will be seeking FDA clearance and approval of assays, creating a next generation imaging system, and developing automation through liquid handlers.